Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
J Tissue Eng Regen Med ; 16(4): 346-354, 2022 04.
Article in English | MEDLINE | ID: mdl-35084808

ABSTRACT

In the ongoing search for the optimal biomaterial for tissue engineered vascular grafts (TEVGs), poly (glycerol sebacate) (PGS) has emerged as a new potential candidate. We have utilized a novel method to create unique, pore-free, extruded PGS grafts with and without a supportive exterior layer of polyglycolic acid (PGA). The 1 mm diameter by 5 mm length TEVGs were implanted in a rat model of infrarenal abdominal aorta interposition grafting. Three months after implantation, TEVGs comprised of extruded PGS with an external PGA braid demonstrated a patency rate of 9/10 (90%) with no signs of dilatation, dehiscence, or rupture. The PGS/PGA graft was remodeled into a neoartery with complete endothelialization of the neoartery lumen and formation of smooth muscle actinin multilayers as demonstrated via immunohistochemistry. Formation and maturation of extracellular matrix material were also observed, with amounts of elastin and collagen comparable to native rat aorta. No significant host inflammatory response was observed. These findings suggest the combination of an extruded PGS tube with an external reinforcing PGA braid is a promising material for small diameter TEVGs.


Subject(s)
Glycerol , Polyglycolic Acid , Animals , Biocompatible Materials , Blood Vessel Prosthesis , Extracellular Matrix , Glycerol/pharmacology , Rats , Tissue Engineering , Tissue Scaffolds
2.
Tissue Eng Part A ; 25(7-8): 632-641, 2019 04.
Article in English | MEDLINE | ID: mdl-30382009

ABSTRACT

IMPACT STATEMENT: We utilized innovative textile technology to create tissue-engineered vascular grafts (TEVGs) comprised exclusively of rapidly degrading material poly(glycolic acid). Our new technology led to robust neotissue formation in the TEVGs, especially extracellular matrix formation, such as elastin. In addition, the rapid degradation of the polymer significantly reduced complications, such as stenosis or calcification, as seen with the use of slow degrading polymers in the majority of previous studies for aortic small diameter TEVGs.


Subject(s)
Tissue Engineering/methods , Animals , Blood Vessel Prosthesis Implantation/methods , Constriction, Pathologic/surgery , Polymers/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL